Schistosoma infections impose significant socioeconomic burdens on affected communities. Chronic illness reduces productivity, limits school attendance, and increases healthcare expenses for families already facing economic hardship. Agricultural workers may experience decreased output due to fatigue and organ damage, undermining local economies. Meanwhile, limited access to effective treatments and preventive measures perpetuates poverty cycles. Strengthening public health infrastructure, expanding diagnostic services, and ensuring affordable access to antiparasitic medications are essential for long-term control. Collaboration with a mebendazole wholesaler can support reliable drug availability, helping health systems respond efficiently and improving overall community resilience against these debilitating parasitic diseases in affected regions.